[Corticotropo-corticoadrenal dynamics in prolonged cortisone treatment].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000494:pharmacology*; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone; D000328:Adult; D001249:Asthma / Q000188:drug therapy; D003095:Collagen Diseases / Q000188:drug therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008199:Lymphadenitis / Q000188:drug therapy; D008797:Metyrapone; D008875:Middle Aged; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D010912:Pituitary-Adrenal Function Tests; D012871:Skin Diseases / Q000188:drug therapy
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
Dinamica corticotropo-corticosurrenalica nel trattamento cortisonico protratto.